Atlas Trials

Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer

Clinical trial NCT00973310 · UNKNOWN

Trial details

NCT number
NCT00973310
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small Cell Lung
Start date
2009-10-01
Primary completion
2016-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.